Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease

Kyle Fink, Andrew T. Crane, Xavier Lévêque, Dylan J. Dues, Lucas D. Huffman, Allison C. Moore, Darren T. Story, Rachel E. DeJonge, Aaron Antcliff, Phillip A. Starski, Ming Lu, Laurent Lescaudron, Julien Rossignol, Gary L. Dunbar

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Induced pluripotent stem cells (iPSCs) show considerable promise for cell replacement therapies for Huntington's disease (HD). Our laboratory has demonstrated that tail-tip fibroblasts, reprogrammed into iPSCs via two adenoviruses, can survive and differentiate into neuronal lineages following transplantation into healthy adult rats. However, the ability of these cells to survive, differentiate, and restore function in a damaged brain is unknown. To this end, adult rats received a regimen of 3-nitropropionic acid (3-NP) to induce behavioral and neuropathological deficits that resemble HD. At 7, 21, and 42 days after the initiation of 3-NP or vehicle, the rats received intrastriatal bilateral transplantation of iPSCs. All rats that received 3-NP and vehicle treatment displayed significant motor impairment, whereas those that received iPSC transplantation after 3-NP treatment had preserved motor function. Histological analysis of the brains of these rats revealed significant decreases in optical densitometric measures in the striatum, lateral ventricle enlargement, as well as an increase in striosome size in all rats receiving 3-NP when compared with sham rats. The 3-NP-treated rats given transplants of iPSCs in the 7- or 21-day groups did not exhibit these deficits. Transplantation of iPSCs at the late-stage (42-day) time point did not protect against the 3-NP-induced neuropathology, despite preserving motor function. Transplanted iPSCs were found to survive and differentiate into region-specific neurons in the striatum of 3-NP rats, at all transplantation time points. Taken together, these results suggest that transplantation of adenovirus-generated iPSCs may provide a potential avenue for therapeutic treatment of HD.

Original languageEnglish (US)
Pages (from-to)620-631
Number of pages12
JournalStem cells translational medicine
Volume3
Issue number5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Huntington Disease
Adenoviridae
Rodentia
Transplantation
Aptitude
3-nitropropionic acid
Lateral Ventricles
Brain
Stem Cell Transplantation
Therapeutics
Cell- and Tissue-Based Therapy
Tail
Fibroblasts
Transplants
Neurons

Keywords

  • 3-Nitropropionic acid
  • Adenovirus
  • Huntington's disease
  • iPSC
  • Stem cell
  • Transplantation

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease. / Fink, Kyle; Crane, Andrew T.; Lévêque, Xavier; Dues, Dylan J.; Huffman, Lucas D.; Moore, Allison C.; Story, Darren T.; DeJonge, Rachel E.; Antcliff, Aaron; Starski, Phillip A.; Lu, Ming; Lescaudron, Laurent; Rossignol, Julien; Dunbar, Gary L.

In: Stem cells translational medicine, Vol. 3, No. 5, 01.01.2014, p. 620-631.

Research output: Contribution to journalArticle

Fink, K, Crane, AT, Lévêque, X, Dues, DJ, Huffman, LD, Moore, AC, Story, DT, DeJonge, RE, Antcliff, A, Starski, PA, Lu, M, Lescaudron, L, Rossignol, J & Dunbar, GL 2014, 'Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease', Stem cells translational medicine, vol. 3, no. 5, pp. 620-631. https://doi.org/10.5966/sctm.2013-0151
Fink, Kyle ; Crane, Andrew T. ; Lévêque, Xavier ; Dues, Dylan J. ; Huffman, Lucas D. ; Moore, Allison C. ; Story, Darren T. ; DeJonge, Rachel E. ; Antcliff, Aaron ; Starski, Phillip A. ; Lu, Ming ; Lescaudron, Laurent ; Rossignol, Julien ; Dunbar, Gary L. / Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease. In: Stem cells translational medicine. 2014 ; Vol. 3, No. 5. pp. 620-631.
@article{0db1a2a9f47140f3b4bf3aaacfe5848a,
title = "Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease",
abstract = "Induced pluripotent stem cells (iPSCs) show considerable promise for cell replacement therapies for Huntington's disease (HD). Our laboratory has demonstrated that tail-tip fibroblasts, reprogrammed into iPSCs via two adenoviruses, can survive and differentiate into neuronal lineages following transplantation into healthy adult rats. However, the ability of these cells to survive, differentiate, and restore function in a damaged brain is unknown. To this end, adult rats received a regimen of 3-nitropropionic acid (3-NP) to induce behavioral and neuropathological deficits that resemble HD. At 7, 21, and 42 days after the initiation of 3-NP or vehicle, the rats received intrastriatal bilateral transplantation of iPSCs. All rats that received 3-NP and vehicle treatment displayed significant motor impairment, whereas those that received iPSC transplantation after 3-NP treatment had preserved motor function. Histological analysis of the brains of these rats revealed significant decreases in optical densitometric measures in the striatum, lateral ventricle enlargement, as well as an increase in striosome size in all rats receiving 3-NP when compared with sham rats. The 3-NP-treated rats given transplants of iPSCs in the 7- or 21-day groups did not exhibit these deficits. Transplantation of iPSCs at the late-stage (42-day) time point did not protect against the 3-NP-induced neuropathology, despite preserving motor function. Transplanted iPSCs were found to survive and differentiate into region-specific neurons in the striatum of 3-NP rats, at all transplantation time points. Taken together, these results suggest that transplantation of adenovirus-generated iPSCs may provide a potential avenue for therapeutic treatment of HD.",
keywords = "3-Nitropropionic acid, Adenovirus, Huntington's disease, iPSC, Stem cell, Transplantation",
author = "Kyle Fink and Crane, {Andrew T.} and Xavier L{\'e}v{\^e}que and Dues, {Dylan J.} and Huffman, {Lucas D.} and Moore, {Allison C.} and Story, {Darren T.} and DeJonge, {Rachel E.} and Aaron Antcliff and Starski, {Phillip A.} and Ming Lu and Laurent Lescaudron and Julien Rossignol and Dunbar, {Gary L.}",
year = "2014",
month = "1",
day = "1",
doi = "10.5966/sctm.2013-0151",
language = "English (US)",
volume = "3",
pages = "620--631",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "5",

}

TY - JOUR

T1 - Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease

AU - Fink, Kyle

AU - Crane, Andrew T.

AU - Lévêque, Xavier

AU - Dues, Dylan J.

AU - Huffman, Lucas D.

AU - Moore, Allison C.

AU - Story, Darren T.

AU - DeJonge, Rachel E.

AU - Antcliff, Aaron

AU - Starski, Phillip A.

AU - Lu, Ming

AU - Lescaudron, Laurent

AU - Rossignol, Julien

AU - Dunbar, Gary L.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Induced pluripotent stem cells (iPSCs) show considerable promise for cell replacement therapies for Huntington's disease (HD). Our laboratory has demonstrated that tail-tip fibroblasts, reprogrammed into iPSCs via two adenoviruses, can survive and differentiate into neuronal lineages following transplantation into healthy adult rats. However, the ability of these cells to survive, differentiate, and restore function in a damaged brain is unknown. To this end, adult rats received a regimen of 3-nitropropionic acid (3-NP) to induce behavioral and neuropathological deficits that resemble HD. At 7, 21, and 42 days after the initiation of 3-NP or vehicle, the rats received intrastriatal bilateral transplantation of iPSCs. All rats that received 3-NP and vehicle treatment displayed significant motor impairment, whereas those that received iPSC transplantation after 3-NP treatment had preserved motor function. Histological analysis of the brains of these rats revealed significant decreases in optical densitometric measures in the striatum, lateral ventricle enlargement, as well as an increase in striosome size in all rats receiving 3-NP when compared with sham rats. The 3-NP-treated rats given transplants of iPSCs in the 7- or 21-day groups did not exhibit these deficits. Transplantation of iPSCs at the late-stage (42-day) time point did not protect against the 3-NP-induced neuropathology, despite preserving motor function. Transplanted iPSCs were found to survive and differentiate into region-specific neurons in the striatum of 3-NP rats, at all transplantation time points. Taken together, these results suggest that transplantation of adenovirus-generated iPSCs may provide a potential avenue for therapeutic treatment of HD.

AB - Induced pluripotent stem cells (iPSCs) show considerable promise for cell replacement therapies for Huntington's disease (HD). Our laboratory has demonstrated that tail-tip fibroblasts, reprogrammed into iPSCs via two adenoviruses, can survive and differentiate into neuronal lineages following transplantation into healthy adult rats. However, the ability of these cells to survive, differentiate, and restore function in a damaged brain is unknown. To this end, adult rats received a regimen of 3-nitropropionic acid (3-NP) to induce behavioral and neuropathological deficits that resemble HD. At 7, 21, and 42 days after the initiation of 3-NP or vehicle, the rats received intrastriatal bilateral transplantation of iPSCs. All rats that received 3-NP and vehicle treatment displayed significant motor impairment, whereas those that received iPSC transplantation after 3-NP treatment had preserved motor function. Histological analysis of the brains of these rats revealed significant decreases in optical densitometric measures in the striatum, lateral ventricle enlargement, as well as an increase in striosome size in all rats receiving 3-NP when compared with sham rats. The 3-NP-treated rats given transplants of iPSCs in the 7- or 21-day groups did not exhibit these deficits. Transplantation of iPSCs at the late-stage (42-day) time point did not protect against the 3-NP-induced neuropathology, despite preserving motor function. Transplanted iPSCs were found to survive and differentiate into region-specific neurons in the striatum of 3-NP rats, at all transplantation time points. Taken together, these results suggest that transplantation of adenovirus-generated iPSCs may provide a potential avenue for therapeutic treatment of HD.

KW - 3-Nitropropionic acid

KW - Adenovirus

KW - Huntington's disease

KW - iPSC

KW - Stem cell

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84899672278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899672278&partnerID=8YFLogxK

U2 - 10.5966/sctm.2013-0151

DO - 10.5966/sctm.2013-0151

M3 - Article

VL - 3

SP - 620

EP - 631

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 5

ER -